help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Published ahead of print on March 30, 2007, doi:10.1164/rccm.200611-1630OC
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
200611-1630OCv1
176/2/162    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Related articles in AJRCCM
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ernst, P.
Right arrow Articles by Suissa, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ernst, P.
Right arrow Articles by Suissa, S.
American Journal of Respiratory and Critical Care Medicine Vol 176. pp. 162-166, (2007)
© 2007 American Thoracic Society
doi: 10.1164/rccm.200611-1630OC

Original Article

Inhaled Corticosteroid Use in Chronic Obstructive Pulmonary Disease and the Risk of Hospitalization for Pneumonia

Pierre Ernst1, Anne V. Gonzalez1, Paul Brassard1 and Samy Suissa1

1 Pharmacoepidemiology Research Unit, Department of Medicine, McGill University Health Centre, Montreal, Quebec, Canada

Correspondence and requests for reprints should be addressed to Pierre Ernst, M.D., Division of Clinical Epidemiology, Ross 4.29, Royal Victoria Hospital, 687 Pine Avenue West, Montreal, PQ, H3A 1A1 Canada. E-mail: pierre.ernst{at}mcgill.ca

Rationale: Inhaled corticosteroids are commonly prescribed to patients with chronic obstructive pulmonary disease (COPD).

Objectives: To examine whether these medications might be associated with an excess risk of pneumonia.

Methods: We conducted a nested case-control study within a cohort of patients with COPD from Quebec, Canada, over the period 1988–2003, identified on the basis of administrative databases linking hospitalization and drug-dispensing information. Each subject hospitalized for pneumonia during follow-up (case subjects) was age and time matched to four control subjects. The effect of the use of inhaled corticosteroids was assessed by conditional logistic regression, after adjusting for comorbidity and COPD severity.

Measurements and Main Results: The cohort included 175,906 patients with COPD of whom 23,942 were hospitalized for pneumonia during follow-up, for a rate of 1.9 per 100 per year, and matched to 95,768 control subjects. The adjusted rate ratio of hospitalization for pneumonia associated with current use of inhaled corticosteroids was 1.70 (95% confidence interval [CI], 1.63–1.77) and 1.53 (95% CI, 1.30–1.80) for pneumonia hospitalization followed by death within 30 days. The rate ratio of hospitalization for pneumonia was greatest with the highest doses of inhaled corticosteroids, equivalent to fluticasone at 1,000 µg/day or more (rate ratio, 2.25; 95% CI, 2.07–2.44). All-cause mortality was similar for patients hospitalized for pneumonia, whether or not they had received inhaled corticosteroids in the recent past (7.4 and 8.2%, respectively).

Conclusions: The use of inhaled corticosteroids is associated with an excess risk of pneumonia hospitalization and of pneumonia hospitalization followed by death within 30 days, among elderly patients with COPD.

Key Words: chronic obstructive pulmonary disease • drug therapy • corticosteroids • inhaled therapy • cohort studies


AT A GLANCE COMMENTARY

Scientific Knowledge on the Subject
A clinical trial has suggested that there may be an excess risk of severe pneumonia in patients using inhaled corticosteroids.

What This Study Adds to the Field
An excess of severe pneumonia requiring hospitalization was seen among patients with chronic obstructive pulmonary disease who were dispensed inhaled corticosteroids. The effect was greatest for those prescribed higher doses in the recent past.

 

Related articles in AJRCCM:

Inhaled Corticosteroids Cause Pneumonia ...or Do They?
Mark Woodhead
AJRCCM 2007 176: 111-112. [Full Text]  



This article has been cited by other articles:


Home page
 ChestHome page
R. Agarwal, A. N. Aggarwal, D. Gupta, and S. K. Jindal
Inhaled Corticosteroids vs Placebo for Preventing COPD Exacerbations: A Systematic Review and Metaregression of Randomized Controlled Trials
Chest, February 1, 2010; 137(2): 318 - 325.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
A. Torres and R. Menendez
Meeting the old man's friend
Thorax, December 1, 2009; 64(12): 1016 - 1017.
[Full Text] [PDF]

Home page
 Infect. Immun.Home page
P. Marti-Lliteras, V. Regueiro, P. Morey, D. W. Hood, C. Saus, J. Sauleda, A. G. N. Agusti, J. A. Bengoechea, and J. Garmendia
Nontypeable Haemophilus influenzae Clearance by Alveolar Macrophages Is Impaired by Exposure to Cigarette Smoke
Infect. Immun., October 1, 2009; 77(10): 4232 - 4242.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
C. Crim, P. M. A. Calverley, J. A. Anderson, B. Celli, G. T. Ferguson, C. Jenkins, P. W. Jones, L. R. Willits, J. C. Yates, and J. Vestbo
Pneumonia risk in COPD patients receiving inhaled corticosteroids alone or in combination: TORCH study results
Eur. Respir. J., September 1, 2009; 34(3): 641 - 647.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
S. Suissa and P. J. Barnes
Inhaled corticosteroids in COPD: the case against
Eur. Respir. J., July 1, 2009; 34(1): 13 - 16.
[Full Text] [PDF]

Home page
 Eur Respir JHome page
G. G. Brusselle, T. Demoor, K. R. Bracke, C-A. Brandsma, and W. Timens
Lymphoid follicles in (very) severe COPD: beneficial or harmful?
Eur. Respir. J., July 1, 2009; 34(1): 219 - 230.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
C. C. Winchester, T. V. Macfarlane, M. Thomas, and D. Price
Antibiotic Prescribing and Outcomes of Lower Respiratory Tract Infection in UK Primary Care
Chest, May 1, 2009; 135(5): 1163 - 1172.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
G. J. Gaschler, M. Skrtic, C. C. J. Zavitz, M. Lindahl, P.-O. Onnervik, T. F. Murphy, S. Sethi, and M. R. Stampfli
Bacteria Challenge in Smoke-exposed Mice Exacerbates Inflammation and Skews the Inflammatory Profile
Am. J. Respir. Crit. Care Med., April 15, 2009; 179(8): 666 - 675.
[Abstract] [Full Text] [PDF]

Home page
 Arch Intern MedHome page
S. Singh, A. V. Amin, and Y. K. Loke
Long-term Use of Inhaled Corticosteroids and the Risk of Pneumonia in Chronic Obstructive Pulmonary Disease: A Meta-analysis
Arch Intern Med, February 9, 2009; 169(3): 219 - 229.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
P. Kardos
Methodological issues in therapeutic trials of COPD
Eur. Respir. J., February 1, 2009; 33(2): 443 - 444.
[Full Text] [PDF]

Home page
 ChestHome page
A. Busacker, J. D. Newell Jr, T. Keefe, E. A. Hoffman, J. C. Granroth, M. Castro, S. Fain, and S. Wenzel
A Multivariate Analysis of Risk Factors for the Air-Trapping Asthmatic Phenotype as Measured by Quantitative CT Analysis
Chest, January 1, 2009; 135(1): 48 - 56.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
M. B. Drummond, E. C. Dasenbrook, M. W. Pitz, D. J. Murphy, and E. Fan
Inhaled Corticosteroids in Patients With Stable Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-analysis
JAMA, November 26, 2008; 300(20): 2407 - 2416.
[Abstract] [Full Text] [PDF]

Home page
 ANN INTERN MEDHome page
T. A. Lee, A. S. Pickard, D. H. Au, B. Bartle, and K. B. Weiss
Risk for Death Associated with Medications for Recently Diagnosed Chronic Obstructive Pulmonary Disease
Ann Intern Med, September 16, 2008; 149(6): 380 - 390.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
S. Suissa
Medications to Modify Lung Function Decline in Chronic Obstructive Pulmonary Disease: Some Hopeful Signs
Am. J. Respir. Crit. Care Med., August 15, 2008; 178(4): 322 - 323.
[Full Text] [PDF]

Home page
 ChestHome page
T. Benfield, P. Lange, and J. Vestbo
COPD Stage and Risk of Hospitalization for Infectious Disease
Chest, July 1, 2008; 134(1): 46 - 53.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
P. Albert and P. M. A. Calverley
Drugs (including oxygen) in severe COPD
Eur. Respir. J., May 1, 2008; 31(5): 1114 - 1124.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
W. MacNee
Update in Chronic Obstructive Pulmonary Disease 2007
Am. J. Respir. Crit. Care Med., April 15, 2008; 177(8): 820 - 829.
[Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
P. Ernst and S. Suissa
Inhaled Corticosteroids and Pneumonia in COPD: An Association Looking for Evidence
Am. J. Respir. Crit. Care Med., March 1, 2008; 177(5): 556 - 556.
[Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
M. O. Turner
Inhaled Corticosteroids and Pneumonia in COPD: An Association Looking for Evidence
Am. J. Respir. Crit. Care Med., March 1, 2008; 177(5): 555 - 556.
[Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
V. Brusasco, E. Crimi, and R. Pellegrino
Airway Inflammation in COPD: Friend or Foe?
Am. J. Respir. Crit. Care Med., September 1, 2007; 176(5): 425 - 426.
[Full Text] [PDF]

Home page
 JWatch Infect. DiseasesHome page
Do Inhaled Corticosteroids Increase Pneumonia Risk in COPD?
Journal Watch Infectious Diseases, July 18, 2007; 2007(718): 4 - 4.
[Full Text]

Home page
 Am. J. Respir. Crit. Care Med.Home page
M. Woodhead
Inhaled Corticosteroids Cause Pneumonia ...or Do They?
Am. J. Respir. Crit. Care Med., July 15, 2007; 176(2): 111 - 112.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2007 American Thoracic Society